InMode (INMD) Cash from Financing Activities (2018 - 2026)
InMode's (INMD) quarterly Cash from Financing Activities came in at -$56.5 million in Q2 2026, down 109.39% year-over-year from $601.5 million in Q2 2025, and down 74.22% quarter-over-quarter from -$32.4 million in Q1 2026.
Powered by 
Analysis
InMode (INMD) Cash from Financing Activities (2018 - 2026) Analysis & Trends
InMode has disclosed Cash from Financing Activities across 9 years of filings, most recently posting -$56.5 million for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 109.39% year-over-year to -$56.5 million; the TTM figure through Jun 2026 stood at -$88.5 million (up 72.41% YoY), while the FY2025 annual figure was -$126.1 million, up 55.42% from the prior year.
- Cash from Financing Activities came in at -$56.5 million for Q2 2026 at InMode, down from -$32.4 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $2.7 million in Q3 2023 to a low of -$118.4 million in Q4 2024.
- Average Cash from Financing Activities over 5 years is -$29.6 million, with a median of $170500.0 recorded in 2022.
- Year-over-year, Cash from Financing Activities jumped 396.18% in 2023 and tumbled 43165.09% in 2024.
- Over 5 years, Cash from Financing Activities stood at $637000.0 in 2022, then plunged by 56.83% to $275000.0 in 2023, then plunged by 43165.09% to -$118.4 million in 2024, then jumped by 100.12% to $137000.0 in 2025, then plunged by 41335.04% to -$56.5 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$56.5 million in Q2 2026, -$32.4 million in Q1 2026, and $137000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -213.50 Mn |
| 10 | InMode | 944.68 Mn | 462.56 Mn | 71.52 Mn | -56.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -56.49 Mn |
| Mar 31, 2026 | -32.43 Mn |
| Dec 31, 2025 | 137,000.00 |
| Sep 30, 2025 | 249,000.00 |
| Jun 30, 2025 | -26.98 Mn |
| Mar 31, 2025 | -99.47 Mn |
| Dec 31, 2024 | -118.43 Mn |
| Sep 30, 2024 | -75.99 Mn |
| Jun 30, 2024 | -88.59 Mn |
| Mar 31, 2024 | 234,000.00 |
| Dec 31, 2023 | 275,000.00 |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 827,000.00 |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 637,000.00 |
| Sep 30, 2022 | 550,000.00 |
| Jun 30, 2022 | 204,000.00 |
| Mar 31, 2022 | -42.48 Mn |
| Dec 31, 2021 | -22.90 Mn |
| Sep 30, 2021 | 5.20 Mn |